Sign in
WithdrawnNo phase

Energy Expenditure and Quality of Life in Epilepsy

Key facts

Who runs it
University of Wisconsin, Madison
Where
Madison, United StatesSee the site
Trial code
Status
Withdrawn
Started
Jun 2023
Ended
Aug 2025
Type of study
Observational
Treatments tested
  • Ketogenic Diet
Record updated
29 June 2023
Why it stopped
decided not to process with study

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • aged 18-45
  • Diagnosis of epilepsy
  • Experience an average of 2 or more seizures per month during the 3 months prior to study
  • Plan to start oral ketogenic diet therapy (e.g. with the modified Atkins diet)
  • Have low average or higher cognitive/intellectual function and are able to complete self-report questionnaires
  • over 18 years of age (no age limit)
  • Diagnosis of epilepsy
  • Experience an average of 2 or more seizures per month during the 3 months prior to study
  • Plan to start oral ketogenic diet therapy (e.g. with the modified Atkins diet)
  • Have low average or higher cognitive/intellectual function and are able to complete self-report questionnaires

Who cannot take part

  • Currently using medications that may cause metabolic and/or absorptive alterations (e.g. diuretics, amphetamines, lipase inhibitors, corticosteroids, etc.)
  • Already on ketogenic therapy
  • Presence of edema, conditions or persistent side effects of medication use (e.g. vomiting, diarrhea, excessive sweating, and burns) that could cause alterations in the body hydration and consequently, be a bias in energy metabolism variables
  • Liver, kidney, or pancreatic disease
  • Fatty acid oxidation disorder or pyruvate carboxylase deficiency
  • Unstable metabolic condition (e.g. persistent sodium <130 or glucose <50)
  • Participants who report being claustrophobic
  • Hypercholesterolemia (cholesterol > 300mg/dL)
  • Currently pregnant or planning on becoming pregnant

Where in United States

  • University of WisconsinMadison, United States

About the trial

What the trial wants to find out

The main objectives of this study are to investigate the influence of the ketogenic diet (KD), standard care for patients assisted in the UW Health Adult Epilepsy Dietary Therapy Clinic, on changes in the frequency and severity of seizures, QoL, energy substrate metabolism, body energy expenditure components, fat mass and fat-free mass in adults with epilepsy. To achieve this objective, twenty-five male and female participants between the ages of 18 and 45 years (or over 18 years for remote participation), who accepted to initiate the KD as a standard of care prescribed by their physician, will be recruited according to inclusion/exclusion criteria. Participants will be on study for 6 months.

The group in the trial

  • Ketogenic Diet

    * Baseline Assessments * Ketogenic diet intervention * 3 and 6 month Assessments

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effects of Ketogenic Diet on Epilepsy: Metabolism and Quality of Life
Record updated
29 June 2023